Evidence map›Paper›PMID 40719412›Full record

ReviewNanomedicine (London, England)2025

Advancements in hydrogel applications for osteoarthritis therapy.

Zhong-Xu Jing, Ying Lv, Yan-Hong Wang, Yu-Fei Feng

Abstract readReview
In one paragraph

Review in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhong-Xu JingCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Hei Longjiang, China.
Ying LvCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Hei Longjiang, China.
Yan-Hong WangCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Hei Longjiang, China.
Yu-Fei FengCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Hei Longjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a prevalent degenerative joint disorder that significantly impacts patient quality of life. Conventional interventions, including pharmacological and surgical approaches, have demonstrated numerous limitations and are inadequate for cartilage regeneration. Recently, hydrogels, as biomaterials characterized by a distinctive three-dimensional network structure, superior biocompatibility, and adjustable mechanical properties, have shown promising potential in OA therapy. In January 2025, a literature review was performed on hydrogel research published between January 2020 and January 2025, utilizing PubMed and Web of Science databases. Due to the foundational and representative nature of the experimental methodologies, two seminal original research articles from 2017 and 2019 were explicitly cited. This article reviews the latest advancements in hydrogel-based OA treatments, focusing on innovative therapeutic strategies such as lubrication enhancement, anti-inflammatory effects, microenvironmental response activation, mesenchymal stem cells and their exosome derivatives, as well as piezoelectric smart hydrogels, with particular emphasis on their application in OA management. Finally, we summarize the clinical research and development of hydrogel products from 2015 to 2025. Despite challenges in OA treatment, such as precise drug delivery and mechanical durability, the potential of hydrogels in personalized medicine and improving therapeutic outcomes positions them as a pivotal direction for future OA therapies.

Indexed as

HydrogelsOsteoarthritisAnimalsAnti-Inflammatory AgentsBiocompatible MaterialsDrug Delivery SystemsHumansMesenchymal Stem CellsAnti-Inflammatory AgentsBiocompatible MaterialsHydrogelscartilage repairdrug deliveryhydrogelinflammatory environmentOA

Identifiers

PMID40719412
PMCPMC12330244

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.